Article
Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
The Urologic clinics of North America - 1 Aug 2021
Byrne Lindsey, Toland Amanda Ewart
Abstract excerpt
More than 40% of the risk of developing prostate cancer (PCa) is from genetic factors. Genome-wide association studies have led to the discovery of more than 140 variants associated with PCa risk. Polygenic risk scores (PRS) generated using these variants show promise in identifying individuals at much higher (and lower) lifetime risk than the average man. PCa PRS also improve the predictive value of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
